[Diphosphonates in the treatment of osteoporosis and in the prevention of associated fractures].
作者信息
De Gregorio M, De Gregorio G
机构信息
Clinica Ortopedica, Università degli Studi di Messina.
出版信息
Clin Ter. 1995 Feb;146(2):123-32.
PMID:7789073
Abstract
Diphosphonates are capable to increase vertebral bone mineral mass in postmenopausal osteoporosis. Because the risk of fractures is related to the reduction of bone mass, the positive effect of diphosphonates most probably produced a decrease in fracture rate. At present these drugs represent a rational option for the treatment of postmenopausal osteoporosis.
摘要
Zotero 插件